IV 
118TH CONGRESS 
2D SESSION 
H. RES. 1283 
Supporting the designation of June 6, 2024, as National Naloxone Awareness 
Day. 
IN THE HOUSE OF REPRESENTATIVES 
JUNE 7, 2024 
Mrs. MCCLAIN (for herself, Mr. TRONE, Ms. KUSTER, Mr. PAPPAS, Ms. 
PETTERSEN, Ms. CRAIG, and Mr. FITZPATRICK) submitted the following 
resolution; which was referred to the Committee on Energy and Com-
merce 
RESOLUTION 
Supporting the designation of June 6, 2024, as National 
Naloxone Awareness Day. 
Whereas the opioid epidemic continues to devastate commu-
nities across the United States, leading to a significant 
loss of life and widespread societal impact; 
Whereas, as of December 2023, opioid overdoses during the 
previous 12 months claimed a reported 81,083 lives in 
the United States; 
Whereas fatal overdoses are often witnessed by a bystander; 
Whereas, in 2023 alone, the Drug Enforcement Administra-
tion seized more than 381,000,000 doses of potentially 
deadly fentanyl, enough to kill every individual in the 
United States; 
VerDate Sep 11 2014 
01:49 Jun 08, 2024
Jkt 049200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6300
E:\BILLS\HR1283.IH
HR1283
kjohnson on DSK7ZCZBW3PROD with $$_JOB
•HRES 1283 IH 
Whereas, according to data from the Centers for Disease 
Control and Prevention, synthetic opioids like fentanyl 
contribute to nearly 70 percent of overdose deaths; 
Whereas naloxone is a safe and effective medication that can 
reverse opioid overdoses and save lives when administered 
promptly by rapidly reversing the effects of opioids; 
Whereas naloxone plays a vital role in preventing long-term 
brain damage and reducing the risk of fatality associated 
with opioid overdoses; 
Whereas the Centers for Disease Control and Prevention has 
declared naloxone to be a key tool in preventing opioid 
overdose deaths; 
Whereas it is imperative to educate individuals, families, 
healthcare professionals, and first responders about— 
(1) the benefits of naloxone, including the potential 
naloxone has to reduce opioid-related fatalities; and 
(2) how to administer naloxone; 
Whereas it is imperative to identify current or potential bar-
riers, including cost, for individuals, organizations, and 
Federal, State, and local governments to obtain and dis-
tribute naloxone; 
Whereas increasing access to naloxone can ensure that indi-
viduals struggling with opioid use disorder have a chance 
at recovery and a future free from the grip of substance 
use disorder; 
Whereas the Food and Drug Administration took action to 
authorize the over-the-counter sale of 4 milligram doses 
of naloxone; and 
Whereas recognizing National Naloxone Awareness Day will 
contribute to the ongoing efforts to educate the public, 
reduce stigma associated with substance use disorder, 
VerDate Sep 11 2014 
01:49 Jun 08, 2024
Jkt 049200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6300
E:\BILLS\HR1283.IH
HR1283
kjohnson on DSK7ZCZBW3PROD with $$_JOB
•HRES 1283 IH 
and promote access to lifesaving naloxone: Now, there-
fore, be it 
Resolved, That the House of Representatives— 
(1) supports the designation of National 
Naloxone Awareness Day; 
(2) recognizes the life-saving benefits of 
naloxone in reversing opioid overdoses and pre-
venting unnecessary deaths; 
(3) acknowledges that increased access to 
naloxone empowers individuals, families, healthcare 
professionals, and first responders to intervene in 
emergency situations and provide immediate assist-
ance to those experiencing an opioid overdose; 
(4) recognizes that National Naloxone Aware-
ness Day serves as an opportunity to educate mem-
bers of the public about the importance of recog-
nizing the signs of opioid overdose and equipping 
themselves with naloxone to save lives; 
(5) encourages Federal, State, and local govern-
ments, as well as private and nonprofit organiza-
tions, to collaborate and allocate resources toward 
increasing naloxone access, education, and distribu-
tion efforts; and 
(6) calls upon Federal agencies, including the 
Substance Abuse and Mental Health Services Ad-
ministration, the Centers for Disease Control and 
VerDate Sep 11 2014 
01:49 Jun 08, 2024
Jkt 049200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6201
E:\BILLS\HR1283.IH
HR1283
kjohnson on DSK7ZCZBW3PROD with $$_JOB
•HRES 1283 IH 
Prevention, the Office of National Drug Control Pol-
icy, the Drug Enforcement Administration, and all 
other Federal agencies engaged in the National 
Drug Control Strategy of the President to continue 
supporting public awareness, harm reduction, and 
overdose and poisoning prevention. 
Æ 
VerDate Sep 11 2014 
01:49 Jun 08, 2024
Jkt 049200
PO 00000
Frm 00004
Fmt 6652
Sfmt 6301
E:\BILLS\HR1283.IH
HR1283
kjohnson on DSK7ZCZBW3PROD with $$_JOB